Table of Contents
Montelukast is a medication commonly used in the management of asthma and allergic rhinitis. It belongs to a class of drugs known as leukotriene receptor antagonists.
Mechanism of Action
Montelukast works by selectively blocking the cysteinyl leukotriene receptor type 1 (CysLT1). Leukotrienes are inflammatory mediators derived from arachidonic acid through the 5-lipoxygenase pathway. During allergic reactions and asthma, leukotrienes such as LTC4, LTD4, and LTE4 are released, leading to bronchoconstriction, increased mucus production, and airway edema.
By antagonizing the CysLT1 receptor, montelukast prevents leukotrienes from binding, thereby reducing airway inflammation, bronchoconstriction, and mucus secretion. This action helps improve airflow and reduce asthma symptoms.
Therapeutic Uses
Montelukast is primarily prescribed for the following conditions:
- Asthma: Used as a controller medication to prevent asthma attacks, especially in mild to moderate cases. It is often used alongside inhaled corticosteroids.
- Allergic Rhinitis: Effective in reducing symptoms such as sneezing, nasal congestion, and runny nose caused by allergies.
- Exercise-Induced Bronchoconstriction: Taken prior to exercise to prevent bronchospasm.
Montelukast is valued for its oral administration, safety profile, and ability to target specific inflammatory pathways involved in allergic and asthmatic responses.
Administration and Considerations
The medication is typically taken once daily in the evening. It is important to adhere to prescribed dosages and inform healthcare providers of any other medications or health conditions.
While generally well tolerated, montelukast can cause side effects such as headache, gastrointestinal discomfort, or, rarely, neuropsychiatric symptoms. Monitoring and patient education are essential for safe use.